Business Context and Reporting Period
This Form 8-K filing by Geovax Labs, Inc. (GOVX) is dated August 27, 2026. The report addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, or debt. However, it discloses the following financial conditions triggering the delisting notice:
- Stock Price: The closing bid price was below the $1.00 minimum requirement for 30 consecutive business days (July 16, 2026, through August 26, 2026).
- Stockholders' Equity: The company is not compliant with the minimum $2,500,000 stockholders' equity requirement under Nasdaq Listing Rule 5550(b).
- Capital Structure: A 1-for-25 reverse stock split was previously effected on January 12, 2026.
Material Changes and Listing Status
On August 27, 2026, the company received a Staff Determination Letter from Nasdaq notifying it of a decision to delist its common stock. The delisting is based on non-compliance with:
- Minimum Bid Price: Failure to maintain a $1.00 per share bid price.
- Compliance Period Restriction: Due to the reverse stock split in January 2026, the company is ineligible for the customary 180-day compliance period.
- Stockholders' Equity: Failure to meet the $2.5 million equity threshold.
Absent a timely hearing request, trading is expected to be suspended at the opening of business on September 8, 2026.
Outlook, Management Commentary, and Risks
Management plans to request a hearing before the Nasdaq Hearings Panel before the September 3, 2026, deadline. A timely request will stay further delisting actions, and the stock will continue to trade on Nasdaq during the appeal process. The filing explicitly states there can be no assurance that the Hearings Panel will grant the request for continued listing or that the company will regain compliance with all applicable listing requirements.
Investor Verification Checklist
- Verify the status of the hearing request with the Nasdaq Hearings Panel by September 3, 2026.
- Monitor the company's stockholders' equity levels to assess progress toward the $2.5 million requirement.
- Track the daily closing bid price to determine if it can sustainably remain above $1.00.
- Review the outcome of the appeal process to confirm if trading suspension on September 8, 2026, is avoided.